top of page

Mistelihoidon        yhteisvaikutus muiden  syöpähoitojen kanssa

Immuunivastetta muuntava hoito

Schad, F., Thronicke, A., Hofheinz, R.-D., Matthes, H., & Grah, C. (2024). Patients with Advanced or Metastasised Non-Small-Cell Lung Cancer with Viscum album L. Therapy in Addition to PD-1/PD-L1 Blockade: A Real-World Data Study. Cancers, 16(8), 1609. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11049173/pdf/cancers-16-01609.pdf 

 

Werthmann PG, Kindermann L, Kienle GS. Chemoimmunotherapy in Advanced Renal Cell Carcinoma: A Case Report of a Long-Term Survivor Adjunctly Treated with Viscum album Extracts. Complementary Medicine Research. March 2019:1-4. DOI:10.1159/000496866 .

Grah C, Kurzeja A, Matthes B, Eichberger A, Wüstfeld A, Kunc K, Weissenstein U, Thieme C, Müssig A, Schad F and Reif M. Immun-Checkpoint-Inhibition plus Viscum album L.- Extrakt beim Lungenkarzinom.  Conference: 60 Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., 2019.

Pneumologie 2019; 73(S 01) DOI: 10.1055/s-0039-1678248

Drozdoff L, Klein E, Kalder M, Brambs C, Kiechle M, Paepke D. Potential interactions of biologically based complementary medicine in gynecological oncology. Integrative Cancer Therapies 2019: 18(10) pp. DOI: 10.1177/1534735419846392.

Thronicke A, Oei S L, Merkle A, Matthes H and Schad F. Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients. Medicines (Basel), 2018;5. DOI: 10.3390/medicines5030100

Thronicke A, Steele M L, Grah C, Matthes B and Schad F. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer. BMC Complement Altern Med, 2017;17:534. DOI: 10.1186/s12906-017-2045-0

bottom of page